Peter Openshaw, Director at CRI, to Speak at Innate Immunity Meeting, Jan 29-31, 2014, San Diego, CA

San Diego, CA, October 19, 2013 --(PR.com)-- Peter Openshaw, Director of the Centre for Respiratory Infection (CRI) at the National Heart and Lung Institute, Imperial College, UK, Professor of Experimental Medicine, and Honorary Physician in the Department of Respiratory Medicine at the St Mary’s Campus of the Imperial College NHS Trust, will give a presentation at the Inaugural Innate Immunity Conference, January 29-31, 2014 in San Diego, CA.

Dr. Openshaw’s research is on the immunology of the lung, viral lung disease, vaccination and immunopathogenesis of viral disease. He was among the first 100 elected Fellows of the Academy of Medical Sciences (1999), and in 2006 he became a member of British Society for Immunology's Council.

Dr. Openshaw was awarded the Chanock Award in 2012 for lifetime contribution to RSV research in Santa Fe, New Mexico and delivered the Croonian lecture at the Royal College of Physicians in February 2013 on the topic of influenza pandemics.

The Inaugural Innate Immunity Conference brings together a mix of academic and industry authoritative experts from leading affiliations (such as the Mt. Sinai School of Medicine, NIAID, 3M Company, Pfizer Vaccine Research, MedImmune, Harvard School of Medicine, NIH, Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis, etc.) to cover many current and relevant aspects of basic, translational or full development in innate immunity and its applicability to human health.

This conference is part of the 2014 Novel Immunotherapeutics Summit, which also includes three other co-located conferences:

1) 6th Immunotherapeutics and Immunomonitoring
2) 12th Cytokines & Inflamation
3) 2nd Immunogenicity and Immunotoxicity

For more information, please visit http://www.gtcbio.com/conference/innate-immunity-overview